EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Therapeutic Potential of Natural Compounds in Neurodegenerative Diseases: Insights from Clinical Trials

Stéphanie Andrade iD, Débora Nunes iD, Meghna Dabur, Maria J Ramalho iD, Maria C Pereira iD, Joana A Loureiro iD

Pharmaceutics · 07.01.2023 · 15 (1) · 212

DOI: 10.3390/pharmaceutics15010212 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pharmaceutics, online erschienen am 07.01.2023. Verfasst von Stéphanie Andrade und 5 weiteren Autor:innen. Beteiligte Einrichtung: LEPABE-Laboratory for Process Engineering, Environment, Biotechnology and Energy, Faculty of Engineering, University of Porto, Rua Dr. Roberto Frias,…. Die Arbeit wurde bisher 55-mal zitiert (Crossref) und nennt 177 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação para a Ciência e Tecnologia, European Regional Development Fund, FCT/MCTES (PIDDAC).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Neurodegenerative diseases are caused by the gradual loss of neurons’ function. These neurological illnesses remain incurable, and current medicines only alleviate the symptoms. Given the social and economic burden caused by the rising frequency of neurodegenerative diseases, there is an urgent need for the development of appropriate therapeutics. Natural compounds are gaining popularity as alternatives to synthetic drugs due to their neuroprotective properties and higher biocompatibility. While natural compounds’ therapeutic effects for neurodegenerative disease treatment have been investigated in numerous in vitro and in vivo studies, only few have moved to clinical trials. This article provides the first systematic review of the clinical trials evaluating natural compounds’ safety and efficacy for the treatment of the five most prevalent neurodegenerative disorders: Alzheimer’s disease, Parkinson’s disease, multiple sclerosis, amyotrophic lateral sclerosis, and Huntington’s disease.

Schlagwörter

Stichwörter der Autor:innen

clinical studycognitive functiondietary supplementhuman studynatural product

Autor:innen und Institutionen

  • LEPABE-Laboratory for Process Engineering, Environment, Biotechnology and Energy, Faculty of Engineering, University of Porto, Rua Dr. Roberto Frias, 4200-465 Porto, Portugal.
  • ALiCE-Associate Laboratory in Chemical Engineering, Faculty of Engineering, University of Porto, Rua Dr. Roberto Frias, 4200-465 Porto, Portugal.

ORCID-Profile: Stéphanie Andrade, Débora Nunes, Maria J Ramalho, Maria C Pereira, Joana A Loureiro

Förderung

  • Fundação para a Ciência e Tecnologia
  • European Regional Development Fund
  • FCT/MCTES (PIDDAC)
  • Norte Portugal Regional Operational Program (NORTE 2020)
  • FCT
  • Scientific Employment Stimulus—Individual Call
  • Prize Maratona da Saúde for Cancer Research

Zitieren

APA

Andrade, S., Nunes, D., Dabur, M., Ramalho, M. J., Pereira, M. C., & Loureiro, J. A. (2023). Therapeutic Potential of Natural Compounds in Neurodegenerative Diseases: Insights from Clinical Trials. Pharmaceutics, 15(1), 212. https://doi.org/10.3390/pharmaceutics15010212

Vancouver

Andrade S, Nunes D, Dabur M, Ramalho MJ, Pereira MC, Loureiro JA. Therapeutic Potential of Natural Compounds in Neurodegenerative Diseases: Insights from Clinical Trials. Pharmaceutics. 2023;15(1):212. doi:10.3390/pharmaceutics15010212

BibTeX
@article{Andrade2023,
  author = {Andrade, Stéphanie and Nunes, Débora and Dabur, Meghna and Ramalho, Maria J and Pereira, Maria C and Loureiro, Joana A},
  title = {Therapeutic Potential of Natural Compounds in Neurodegenerative Diseases: Insights from Clinical Trials},
  journal = {Pharmaceutics},
  year = {2023},
  volume = {15},
  number = {1},
  pages = {212},
  doi = {10.3390/pharmaceutics15010212}
}
Kostenlos starten →